ALISO VIEJO, Calif., Feb. 26, 2019 /PRNewswire/ -- Vertos Medical Inc., a leader in the development of innovative, minimally invasive treatments for lumbar spinal stenosis (LSS), announced today that ...

Medical technologies giant Stryker announced on Tuesday, October 1st, that it completed the acquisition of Vertos Medical for an undisclosed amount. Vertos Medical is a privately held company ...

Medical device maker Vertos Medical raked in $26 million on Wednesday in a Series C funding round led by Norwest Venture Partners. The company, which is based in Aliso Viejo, California, develops ...

ALISO VIEJO, Calif., March 7, 2017 /PRNewswire/ -- Vertos Medical, a medical device company committed to developing innovative, minimally invasive treatments for lumbar spinal stenosis (LSS), has ...

(RTTNews) - Stryker Corporation (SYK), a medical technology company, on Thursday announced a deal to buy Vertos Medical Inc., a privately held provider of a minimally invasive solution for treating ...

Portage, Michigan, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire Vertos Medical Inc., a privately ...

Stryker Corp. continued its aggressive M&A program this year with the planned acquisition of Vertos Medical Inc. Vertos offers a minimally invasive lumbar decompression (Mild) solution for chronic ...

Patients undergoing Vertos Medical’s minimally invasive lumbar spinal stenosis procedure will receive increased reimbursement under new CMS rules, according to a Dec. 8 news release. Starting Jan. 1, ...

Vertos Medical Inc. set a goal for major expansion this year. The provider of minimally invasive treatments for back pain is finding believers for its plans. On June 7, the Aliso Viejo-based company ...

Vertos Medical Inc. is moving to a bigger headquarters within Aliso Viejo later this year as it bolsters training for surgeons and plans to hire. The company, which makes devices to treat spinal ...

Broad access to the mild procedure has been granted for Medicare patients via a CMS-approved claims-analysis study that will passively collect and analyze real-world data to demonstrate the role of ...